LIVANOVA PLC (LIVN) Fundamental Analysis & Valuation

NASDAQ:LIVN • GB00BYMT0J19

Current stock price

63.3 USD
+0.9 (+1.44%)
At close:
63.3 USD
0 (0%)
After Hours:

This LIVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. LIVN Profitability Analysis

1.1 Basic Checks

  • LIVN had positive earnings in the past year.
  • In the past year LIVN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: LIVN reported negative net income in multiple years.
  • LIVN had a positive operating cash flow in each of the past 5 years.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • LIVN has a Return On Assets of -9.30%. This is in the better half of the industry: LIVN outperforms 62.43% of its industry peers.
  • With a decent Return On Equity value of -20.21%, LIVN is doing good in the industry, outperforming 60.85% of the companies in the same industry.
  • LIVN's Return On Invested Capital of 8.12% is amongst the best of the industry. LIVN outperforms 83.07% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LIVN is below the industry average of 9.31%.
  • The 3 year average ROIC (5.19%) for LIVN is below the current ROIC(8.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROIC 8.12%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 14.69%, LIVN belongs to the top of the industry, outperforming 82.54% of the companies in the same industry.
  • LIVN's Operating Margin has improved in the last couple of years.
  • LIVN has a better Gross Margin (68.04%) than 75.13% of its industry peers.
  • In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 14.69%
PM (TTM) N/A
GM 68.04%
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. LIVN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
  • The number of shares outstanding for LIVN has been increased compared to 1 year ago.
  • The number of shares outstanding for LIVN has been increased compared to 5 years ago.
  • Compared to 1 year ago, LIVN has an improved debt to assets ratio.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.77, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.77, LIVN perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • LIVN has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as LIVN would need 2.17 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 2.17, LIVN belongs to the best of the industry, outperforming 86.77% of the companies in the same industry.
  • LIVN has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • LIVN has a Debt to Equity ratio of 0.29. This is comparable to the rest of the industry: LIVN outperforms 52.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Altman-Z 1.77
ROIC/WACC0.93
WACC8.7%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • LIVN has a Current Ratio of 1.36. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN has a worse Current ratio (1.36) than 78.84% of its industry peers.
  • LIVN has a Quick Ratio of 1.16. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • LIVN has a worse Quick ratio (1.16) than 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.16
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LIVN Growth Analysis

3.1 Past

  • LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.73%, which is quite good.
  • Measured over the past years, LIVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.16% on average per year.
  • The Revenue has grown by 10.74% in the past year. This is quite good.
  • The Revenue has been growing by 8.24% on average over the past years. This is quite good.
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%

3.2 Future

  • Based on estimates for the next years, LIVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.89% on average per year.
  • LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.16% yearly.
EPS Next Y9.85%
EPS Next 2Y8.87%
EPS Next 3Y9.5%
EPS Next 5Y10.89%
Revenue Next Year7.96%
Revenue Next 2Y7.4%
Revenue Next 3Y7.48%
Revenue Next 5Y6.16%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. LIVN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.23, which indicates a correct valuation of LIVN.
  • Based on the Price/Earnings ratio, LIVN is valued cheaper than 85.19% of the companies in the same industry.
  • LIVN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.50.
  • A Price/Forward Earnings ratio of 14.78 indicates a correct valuation of LIVN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 86.24% of the companies listed in the same industry.
  • LIVN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.67.
Industry RankSector Rank
PE 16.23
Fwd PE 14.78
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaply inside the industry as 85.19% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LIVN is valued cheaper than 87.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.98
EV/EBITDA 12.6
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.65
PEG (5Y)0.65
EPS Next 2Y8.87%
EPS Next 3Y9.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LIVN Dividend Analysis

5.1 Amount

  • No dividends for LIVN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVN Fundamentals: All Metrics, Ratios and Statistics

LIVANOVA PLC

NASDAQ:LIVN (3/25/2026, 4:30:02 PM)

After market: 63.3 0 (0%)

63.3

+0.9 (+1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners105.28%
Inst Owner Change-2.13%
Ins Owners0.27%
Ins Owner Change0.52%
Market Cap3.46B
Revenue(TTM)1.39B
Net Income(TTM)-242.47M
Analysts82.35
Price Target73.19 (15.62%)
Short Float %4.42%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.93%
Min EPS beat(2)3.44%
Max EPS beat(2)18.42%
EPS beat(4)4
Avg EPS beat(4)13.83%
Min EPS beat(4)3.44%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)17.63%
EPS beat(12)11
Avg EPS beat(12)17.8%
EPS beat(16)14
Avg EPS beat(16)14%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.14%
Max Revenue beat(2)2.12%
Revenue beat(4)4
Avg Revenue beat(4)2.26%
Min Revenue beat(4)0.14%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.08%
Revenue beat(12)11
Avg Revenue beat(12)3.31%
Revenue beat(16)14
Avg Revenue beat(16)2.76%
PT rev (1m)0%
PT rev (3m)5.94%
EPS NQ rev (1m)-1.11%
EPS NQ rev (3m)-0.02%
EPS NY rev (1m)1.61%
EPS NY rev (3m)1.53%
Revenue NQ rev (1m)1.87%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)1.2%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 16.23
Fwd PE 14.78
P/S 2.49
P/FCF 19.98
P/OCF 13.61
P/B 2.88
P/tB 19.54
EV/EBITDA 12.6
EPS(TTM)3.9
EY6.16%
EPS(NY)4.28
Fwd EY6.77%
FCF(TTM)3.17
FCFY5.01%
OCF(TTM)4.65
OCFY7.35%
SpS25.38
BVpS21.94
TBVpS3.24
PEG (NY)1.65
PEG (5Y)0.65
Graham Number43.88
Profitability
Industry RankSector Rank
ROA -9.3%
ROE -20.21%
ROCE 11.34%
ROIC 8.12%
ROICexc 12.57%
ROICexgc 104.62%
OM 14.69%
PM (TTM) N/A
GM 68.04%
FCFM 12.48%
ROA(3y)-2.02%
ROA(5y)-3.2%
ROE(3y)-4.68%
ROE(5y)-6.34%
ROIC(3y)5.19%
ROIC(5y)4.15%
ROICexc(3y)7.23%
ROICexc(5y)5.51%
ROICexgc(3y)42.15%
ROICexgc(5y)N/A
ROCE(3y)7.24%
ROCE(5y)5.79%
ROICexgc growth 3Y126.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y56.54%
ROICexc growth 5YN/A
OM growth 3Y22.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.73%
GM growth 5Y1.24%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.17
Debt/EBITDA 1.38
Cap/Depr 175.19%
Cap/Sales 5.84%
Interest Coverage 6.56
Cash Conversion 101.65%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.16
Altman-Z 1.77
F-Score5
WACC8.7%
ROIC/WACC0.93
Cap/Depr(3y)118.73%
Cap/Depr(5y)92.37%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
EPS Next Y9.85%
EPS Next 2Y8.87%
EPS Next 3Y9.5%
EPS Next 5Y10.89%
Revenue 1Y (TTM)10.74%
Revenue growth 3Y10.75%
Revenue growth 5Y8.24%
Sales Q2Q%12.15%
Revenue Next Year7.96%
Revenue Next 2Y7.4%
Revenue Next 3Y7.48%
Revenue Next 5Y6.16%
EBIT growth 1Y25.59%
EBIT growth 3Y35.73%
EBIT growth 5YN/A
EBIT Next Year27.48%
EBIT Next 3Y13.13%
EBIT Next 5Y-0.2%
FCF growth 1Y27.48%
FCF growth 3Y58.64%
FCF growth 5YN/A
OCF growth 1Y38.95%
OCF growth 3Y53.79%
OCF growth 5YN/A

LIVANOVA PLC / LIVN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 9.85% in the next year.